SCHEDULE: BlackRock Discloses Stake in Hyperfine Inc.
Ownership Disclosure
BlackRock, Inc. has reported a beneficial ownership of 5.5% in Hyperfine Inc.'s Class A Stock as of June 30, 2026.
Summary
- BlackRock, Inc. has filed a Schedule 13G, indicating its beneficial ownership of Hyperfine Inc.'s Class A Stock.
- As of June 30, 2026, BlackRock beneficially owns 4,671,587 shares, representing 5.5% of the class of securities.
- The filing specifies sole voting power for 4,605,420 shares and sole dispositive power for 4,671,587 shares.
- BlackRock, Inc. is organized under the laws of Delaware.
- The principal business office of BlackRock, Inc. is located at 50 Hudson Yards, New York, NY 10001.
- The issuer, Hyperfine Inc., has its principal executive offices at 351 New Whitfield Street, Guilford, CT 06437.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. It's a standard disclosure of ownership by a major institutional investor, providing information on stake size but not on the company's operational performance or future prospects.
Positives
- BlackRock, a significant institutional investor, has disclosed a substantial stake in Hyperfine Inc., which could signal confidence in the company's prospects.
- The filing indicates BlackRock's clear voting and dispositive power over its holdings, suggesting a stable investment position.
Risks
- The filing does not contain specific risk factors related to Hyperfine Inc. itself, as it is a Schedule 13G filing by an institutional investor.
- Potential risks for Hyperfine Inc. would be detailed in its own SEC filings (e.g., 10-K, 10-Q, 8-K).
Future Outlook
This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from Hyperfine Inc.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors crossing certain ownership thresholds. BlackRock's filing indicates a significant investment in Hyperfine Inc., a company likely operating in the medical technology or diagnostics sector, given its name.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Revocation | The Power of Attorney dated January 21, 2025, revokes the previous Power of Attorney dated April 30, 2023. | 2025-01-21 | Ensures that the current designated attorneys-in-fact are authorized for reporting requirements, superseding older authorizations. |
Stakeholder Impact
- Shareholders: The disclosure of a significant stake by BlackRock may be viewed positively, potentially indicating institutional support and confidence in the company's value.
- Management: The filing confirms BlackRock's status as a significant shareholder, which could influence future engagement on corporate strategy.
- Creditors: No direct impact is indicated by this ownership disclosure.
Next Steps
- BlackRock will continue to monitor its holdings in Hyperfine Inc.
- Hyperfine Inc. will continue its business operations and regulatory reporting.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Previous Power of Attorney dated April 30, 2023, revoked by the new filing. |
| 2025-01-21 | Date of execution of the new Power of Attorney by BlackRock, Inc. |
| 2026-06-30 | Date of Event Which Requires Filing of this Statement (Reporting Date). |
Keywords
Schedule 13G, BlackRock, Hyperfine Inc., Class A Stock, Beneficial Ownership, Institutional Investor, Securities, Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.